Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01758211
Other study ID # AVM-125-FMRI
Secondary ID
Status Recruiting
Phase Phase 3
First received December 26, 2012
Last updated March 1, 2013
Start date January 2013
Est. completion date June 2015

Study information

Verified date March 2013
Source Beijing Tiantan Hospital
Contact Yong Cao, MD
Phone 861067096510
Email caoyong6@hotmail.com
Is FDA regulated No
Health authority China: Ministry of Health
Study type Interventional

Clinical Trial Summary

Little is known about the effect of fMRI navigation in the intracranial arteriovenous malformation surgery. The investigators aim to perform a multicenter prospective randomized single -blind clinical trial to assess the effect and safety of fMRI navigation in the brain arteriovenous malformation surgery.


Description:

Intracranial arteriovenous malformations (AVMs) are congenital lesions that consist of multiple arteries and veins, connecting as a fistula without an intervening normal capillary bed. Surgical removal is thought as a major treatment option for AVMs. However, compared with stereotaxic radiosurgery and endovascular embolization, microsurgery of AVMs is regarded with high mortality and morbidity, particular for high level classification AVMs .

Blood oxygen level dependent fMRI can be used to mapping the motor and language regions of the brain noninvasively. It has been one of the most advanced functional imaging techniques and it has quickly grown to be a vital tool for clinical and cognitive neuroscience research. Many clinical researches have been reported about the utility of fMRI in brain tumor surgery. However, the effect of fMRI navigation for neurofunction protection in the intracranial arteriovenous malformation surgery was unclear.

We aim to perform a multicenter prospective randomized single -blind clinical trial to assess the safety and effect of fMRI navigation in the intracranial AVMs surgery. We hypothesize that application of blood oxygen level dependent fMRI is able to improve long term prognosis of patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 60 Years
Eligibility Inclusion Criteria:

1. Diagnosis of intracranial AVM by DSA/CT/MRI

2. Age from 12-60 years

3. Be suitable for microsurgery treatment

4. All patients are able to cooperate with the fMRI examination

5. All patients gave written informed consent

Exclusion Criteria:

1. Patients with age < 12 years or > 60 years

2. Various conditions unable to meet the indications for microsurgery treatment

3. Intracranial hemorrhage need emergency surgery

4. Patients can not cooperate with fMRI examination

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
fMRI Navigation AVM resection
intraoperative fMRI navigation guided resection in AVM patients
conventional resection
conventional resection in AVM patients

Locations

Country Name City State
China Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Tiantan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary modified Ranking Scale The scale runs from 0-6, running from perfect health without symptoms to death. 0-No symptoms.
No significant disability. Able to carry out all usual activities, despite some symptoms.
Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
Moderate disability. Requires some help, but able to walk unassisted.
Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
Dead.
six months after operation Yes
Secondary Postoperative complications Post operative epilepsy seizure, hemorrhage,infarction. six months after operation Yes
See also
  Status Clinical Trial Phase
Completed NCT04553549 - Safety and Feasibility of the Infinity Catheter for Radial Access
Recruiting NCT02868008 - Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations N/A
Completed NCT03209804 - Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room N/A
Recruiting NCT04328181 - Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT) N/A
Recruiting NCT01803685 - Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China N/A
Recruiting NCT05058482 - Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations N/A
Completed NCT01689402 - MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Recruiting NCT03731000 - PHIL® Embolic System Pediatric IDE N/A
Recruiting NCT05933330 - Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database